Journal article
Canadian atrial fibrillation anticoaguiation (CAFA) study
Abstract
The Canadian Atrial Fibrillation Anticoagulation Study was a randomized double-blind placebo-controlled trial to assess the potential of warfarin to reduce systemic thromboembolism and its inherent risk of hemorrhage. As a result of the publication of two other "positive" studies of similar design and objective, this study was stopped early before completion of its planned recruitment of 630 patients. There were 187 patients randomized to …
Authors
Connolly SJ; Laupacis A; Gent M; Roberts RS; Cairns JA; Joyner C; Coinvestigators FTCS
Journal
Journal of the American College of Cardiology, Vol. 18, No. 2, pp. 349–355
Publisher
Elsevier
Publication Date
8 1991
DOI
10.1016/0735-1097(91)90585-w
ISSN
0735-1097